» Articles » PMID: 14726344

Presentation on Websites of Possible Benefits and Harms from Screening for Breast Cancer: Cross Sectional Study

Overview
Journal BMJ
Specialty General Medicine
Date 2004 Jan 17
PMID 14726344
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate whether information on mammographic screening presented on websites by interest groups is balanced, is independent of source of funding, and reflects recent findings.

Design: Cross sectional study using a checklist with 17 information items.

Setting: 27 websites in Scandinavian and English speaking countries.

Results: The 13 sites from advocacy groups and the 11 from governmental institutions all recommended mammographic screening, whereas the three from consumer organisations questioned screening (P = 0.0007). All the advocacy groups accepted industry funding, apparently without restrictions. In contrast the three consumer organisations acknowledged the risk of bias related to industry funding, and two of them did not accept such funding at all. Advocacy groups and governmental organisations favoured information items that shed positive light on screening. The major harms of screening, overdiagnosis and overtreatment, were mentioned by only four of these groups, but by all three sites from consumer organisations (P = 0.02). In addition, the chosen information was often misleading or erroneous. The selection of information items for websites did not reflect recent findings, apart from the consumer sites, which were much more balanced and comprehensive than other sites (median of 9 information items v 3 items, P = 0.03).

Conclusions: The information material provided by professional advocacy groups and governmental organisations is information poor and severely biased in favour of screening. Few websites live up to accepted standards for informed consent such as those stated in the General Medical Council's guidelines.

Citing Articles

Mammography screening: Eliciting the voices of informed citizens.

Jensen M, Hansen K, Siersma V, Brodersen J PLoS One. 2025; 20(1):e0317263.

PMID: 39787123 PMC: 11717236. DOI: 10.1371/journal.pone.0317263.


Online Provision of and Health Information: A Search Engine Driven Systematic Web-Based Analysis.

Gootzen T, Kalra A, Sarig K, Sobocan M, Oxley S, Dworschak N Cancers (Basel). 2024; 16(13).

PMID: 39001386 PMC: 11240379. DOI: 10.3390/cancers16132324.


Deaths and cardiopulmonary events following colorectal cancer screening-A systematic review with meta-analyses.

Martiny F, Bie A, Jauernik C, Rahbek O, Nielsen S, Gram E PLoS One. 2024; 19(3):e0295900.

PMID: 38483910 PMC: 10939197. DOI: 10.1371/journal.pone.0295900.


Questioning 'Informed Choice' in Medical Screening: The Role of Neoliberal Rhetoric, Culture, and Social Context.

Gram E, Jonsson A, Brandt Brodersen J, Damhus C Healthcare (Basel). 2023; 11(9).

PMID: 37174772 PMC: 10178002. DOI: 10.3390/healthcare11091230.


PROTOCOL: Conflict of interest issues when engaging stakeholders in health and healthcare guideline development: a systematic review.

Khabsa J, Petkovic J, Riddle A, Lytvyn L, Magwood O, Atwere P Campbell Syst Rev. 2023; 18(2):e1232.

PMID: 36911340 PMC: 9013401. DOI: 10.1002/cl2.1232.


References
1.
Goodare H, Dimmer C, Page K . Screening mammography: setting the record straight. Lancet. 2002; 359(9304):442. DOI: 10.1016/S0140-6736(02)07571-2. View

2.
Olsen O, Gotzsche P . Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2001; (4):CD001877. DOI: 10.1002/14651858.CD001877. View

3.
Olsen O, Gotzsche P . Cochrane review on screening for breast cancer with mammography. Lancet. 2001; 358(9290):1340-2. DOI: 10.1016/S0140-6736(01)06449-2. View

4.
. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet. 2000; 355(9217):1757-70. View

5.
Nystrom L, Rutqvist L, Wall S, Lindgren A, Lindqvist M, Ryden S . Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet. 1993; 341(8851):973-8. DOI: 10.1016/0140-6736(93)91067-v. View